ClinicalTrials.govpublic full text
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
parkinson disease, dyskinesia, drug-induced, dyskinesias, parkinson's disease, dyskinesia, levodopa-induced dyskinesia, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909015
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.